When the future of healthcare is imagined, terms like personalized medicine are bandied about quite frequently. Dramatic progress in next-generation sequencing technology has resulted in the $1,000 genome from Illumina making the idea of personalized, targeted medicine more than just a pipe dream. The hope is that by unlocking the relationship between genetic variation and disease states, drug and diagnostic companies can develop tests and medications that can diagnose people quickly, and treat them more effectively based on their genetic makeup.
Hey, check out all the engineering jobs. Post your resume today!
